alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENTS OF OPERATIONS INCLUDED IN
THE REGISTRANT'S FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 1999 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                                                           <C>
<PERIOD-TYPE>                                                 9-MOS
<FISCAL-YEAR-END>                                             SEP-30-1999
<PERIOD-START>                                                OCT-01-1998
<PERIOD-END>                                                  JUN-30-1999
<CASH>                                                        815,081
<SECURITIES>                                                  0
<RECEIVABLES>                                                 1,849,648
<ALLOWANCES>                                                  (104,093)
<INVENTORY>                                                   12,658,574
<CURRENT-ASSETS>                                              22,084,039
<PP&E>                                                        8,095,872
<DEPRECIATION>                                                (4,355,367)
<TOTAL-ASSETS>                                                49,362,977
<CURRENT-LIABILITIES>                                         26,136,057
<BONDS>                                                       0
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   3,841
<COMMON>                                                      1,601
<OTHER-SE>                                                    14,093,631
<TOTAL-LIABILITY-AND-EQUITY>                                  49,362,977
<SALES>                                                       56,442,962
<TOTAL-REVENUES>                                              56,442,962
<CGS>                                                         28,613,001
<TOTAL-COSTS>                                                 33,769,557
<OTHER-EXPENSES>                                              0
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                            1,701,432
<INCOME-PRETAX>                                               (7,641,028)
<INCOME-TAX>                                                  0
<INCOME-CONTINUING>                                           (7,641,028)
<DISCONTINUED>                                                (37,386)
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                                  (7,678,414)
<EPS-BASIC>                                                   (0.63)
<EPS-DILUTED>                                                 (0.61)



</TABLE>
Richard Allen CULBERTSON, petitioner, v. Nancy A. BERRYHILL, Acting Commissioner of Social Security.

No. 17-773.

Supreme Court of the United States

Oct. 1, 2018.

Motion of the Solicitor General for divided argument granted.
Gregory Alan KOKAL, petitioner, v. Julie L. JONES, Secretary, Florida Department of Corrections.

No. 18-5330.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Florida denied.
AO 435

(Rev. 10/23)

ADMINISTRATIVE OFFICE OF THE UNITED STATES COURTS FOR COURT USE ONLY

TRANSCRIPT ORDER DUE DATE:

Please Read Instructions:

1. NAME 2. PHONE NUMBER 3. DATE

4. DELIVERY ADDRESS OR EMAIL 5. CITY 6. STATE 7. ZIP CODE

8. CASE NUMBER 9. JUDGE DATES OF PROCEEDINGS

10. FROM 11. TO

12. CASE NAME LOCATION OF PROCEEDINGS

13. CITY 14. STATE

15. ORDER FOR

’ APPEAL ’ CRIMINAL ’ CRIMINAL JUSTICE ACT ’ BANKRUPTCY

’ NON-APPEAL ’ CIVIL ’ IN FORMA PAUPERIS ’ OTHER (Specify)

16. TRANSCRIPT REQUESTED (Specify portion(s) and date(s) of proceeding(s) for which transcript is requested)

PORTIONS DATE(S) PORTION(S) DATE(S)

’ VOIR DIRE ’ TESTIMONY (Specify Witness)

’ OPENING STATEMENT (Plaintiff)

’ OPENING STATEMENT (Defendant)

’ CLOSING ARGUMENT (Plaintiff) ’ PRE-TRIAL PROCEEDING (Spcy)

’ CLOSING ARGUMENT (Defendant)

’ OPINION OF COURT

’ JURY INSTRUCTIONS ’ OTHER (Specify)

’ SENTENCING

’ BAIL HEARING

17. ORDER

CATEGORY

ORIGINAL

(Includes Certified Copy to

Clerk for Records of the Court)

FIRST COPY ADDITIONAL

COPIES NO. OF PAGES ESTIMATE COSTS

30-Day

NO. OF COPIES

’ ’

14-Day

NO. OF COPIES

’ ’

7-Day

NO. OF COPIES

’ ’

3-Day

NO. OF COPIES

’ ’

Next-Day

NO. OF COPIES

’ ’

2-Hour

NO. OF COPIES

’ ’

REALTIME ’ ’

CERTIFICATION (18. & 19.)

By signing below, I certify that I will pay all charges

(deposit plus additional).

ESTIMATE TOTAL

$ 0.00

18. SIGNATURE PROCESSED BY

19. DATE PHONE NUMBER

TRANSCRIPT TO BE PREPARED BY COURT ADDRESS

DATE BY

ORDER RECEIVED

DEPOSIT PAID DEPOSIT PAID

TRANSCRIPT ORDERED TOTAL CHARGES $ 0.00

TRANSCRIPT RECEIVED LESS DEPOSIT $ 0.00

ORDERING PARTY NOTIFIED

TO PICK UP TRANSCRIPT TOTAL REFUNDED

PARTY RECEIVED TRANSCRIPT TOTAL DUE $ 0.00

DISTRIBUTION: COURT COPY TRANSCRIPTION COPY ORDER RECEIPT ORDER COPY

Instructions Marc Fenster (310) 826-7474 10/2/2024 rak_headwater@raklaw.com Los Angeles CA 90025 2:23-CV-0103-JRG-RSP Roy S. Payne 10/2/2024 10/2/2024 Headwater Research LLC v. Samsung Electronics America, Inc. et al.Marshall Texas Motions Hearing 10/2/2024 1

0.00 /s/ Marc Fenster 10/2/2024 0.00 0.00 0.00 Print Save As... Reset

Case 2:23-cv-00103-JRG-RSP Document 160 Filed 10/02/24 Page 1 of 1 PageID #: 6082
**Exhibit 31.2** 

Certification of Principal Financial Officer

 

I, James A. Cochran,  Chief Financial Officer of Turbochef Technologies, Inc., certify that: 

 

1. I have reviewed this annual report on Form 10-K/A of Turbochef Technologies, Inc.; 

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; 

 

3. Based on my knowledge, the financial statements, and other financialinformation included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; 

 

4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have: 

 

(a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; 

 

(b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to thefiling date of this annual report (the “Evaluation Date”); and 

 

(c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; 

 

5. The registrant’s other certifying officers and I have disclosed, basedon our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): 

 

(a) all significant deficiencies in the design or operation of internal controls which could adversely affectthe registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and 

 

(b) any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’s internal controls; and 

 

6. The registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that couldsignificantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. 

 

Date: December 6, 2004

 

/s/ James A. Cochran                

James A. Cochran

Chief Financial Officer
Anthony MAYES, Jr., petitioner, v. UNITED STATES.

No. 18-6102.

Supreme Court of the United States

Oct. 29, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
Edwin C. COLEMAN, petitioner, v. Carrie M. WARD.

No. 18-5711.

Supreme Court of the United States

Oct. 29, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
<PAGE>
 
                                  EXHIBIT 23

                        CONSENT OF INDEPENDENT AUDITORS


     We consent to the incorporation by reference in the Registration Statement
(Form S-3 No. 333-38611) of JDN Realty Corporation and the related Prospectus,
the Registration Statement (Form S-3 No. 33-90868) pertaining to the JDN Realty
Corporation Dividend Reinvestment and Stock Purchase Plan and in the related
Prospectus, the Registration Statement (Form S-8 No. 333-1848) pertaining to the
JDN Realty Corporation 1993 Incentive Stock Plan, the JDN Realty Corporation
1993 Non-Employee Director Stock Option Plan, and the JDN Realty Corporation
1995 Employee Stock Purchase Plan and in the related Prospectus of our report
dated February 27, 1999, with respect to the consolidated financial statements
and schedules of JDN Realty Corporation included in the Annual Report (Form 10-
K) for the year ended December 31, 1998.


                                      ERNST & YOUNG LLP


Atlanta, Georgia
March 23, 1999
Exhibit 10.1

 

Fourth Amendment to Employment Agreement

 

This Fourth Amendment to Employment Agreement (this “Amendment”), dated as of March 12, 2019, is entered into between Intrepid Potash, Inc., a Delaware corporation (the “Company”), and Robert P. Jornayvaz III (“Executive”).

 

Executive is the Executive Chairman of the Board, President, and Chief Executive Officer of the Company and is serving in this capacity on terms and conditions set forth in an Amended and Restated Employment Agreement, dated as of May 19, 2010, and amended as of February 23, 2011, February 14, 2013, and March 22, 2016 (the “Agreement”).

 

The current term of the Agreement expires on April 18, 2019.  The Company and Executive wish to amend the Agreement to extend the term as set forth below.

 

In consideration of the mutual promises and agreements set forth below, the Company and Executive agree as follows:

 

1.              Paragraph 1 of the Agreement is hereby amended and restated, effective as of April 18, 2019, in its entirety to read as follows:

 

“              1.             TERM OF AGREEMENT:  Subject to the terms of this Amended Agreement, the Company agrees to continue to employ Executive pursuant to this Amended Agreement, and Executive hereby accepts such continued employment pursuant to this Amended Agreement, effective as of May 19, 2010 (the “Effective Date”).  Executive’s employment pursuant to this Amended Agreement shall be extended for a term of three years commencing on April 19, 2019, and ending on April 18, 2022, subject to earlier termination as provided in paragraph 4, herein (the “Term”).”

 

2.              Except as expressly modified in this Amendment, the terms and conditions of the Agreement are unchanged and remain in full force and effect.

 

IN WITNESS WHEREOF, the Company and Executive, intending to be legally bound, have executed this Amendment on the day and year first above written.

 

	
 
    	
INTREPID POTASH, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Erica K. Wyatt
    
	
 
    	
 
    	
Name:   Erica K. Wyatt
    
	
 
    	
 
    	
Title:   Chief Human Resources Officer
    
	
 
    	
 
    	
 
    
	
 
    	
ROBERT   P. JORNAYVAZ III
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
/s/   Robert P. Jornayvaz III
I

106TH CONGRESS

1ST SESSION H. R. 1909

To make supplemental appropriations for fiscal year 1999 to ensure the

inclusion of commonly used pesticides in State source water assessment

programs, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

MAY 24, 1999

Mr. ANDREWS introduced the following bill; which was referred to the

Committee on Appropriations

A BILL

To make supplemental appropriations for fiscal year 1999

to ensure the inclusion of commonly used pesticides in

State source water assessment programs, and for other

purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 1909 IH

1 SECTION 1. SUPPLEMENTAL APPROPRIATIONS TO ENSURE

2 INCLUSION OF COMMONLY USED PESTICIDES

3 IN STATE SOURCE WATER ASSESSMENT PRO4 GRAMS.

5 The following sums are appropriated, out of any

6 money in the Treasury not otherwise appropriated, to pro7 vide supplemental appropriations for fiscal year 1999:

8 ENVIRONMENTAL PROTECTION AGENCY

9 STATE AND TRIBAL ASSISTANCE GRANTS

10 For an additional amount for ‘‘State and Tribal As11 sistance Grants’’, for grants for the Drinking Water State

12 Revolving Funds under section 1452 of the Safe Drinking

13 Water Act (42 U.S.C. 300j–12) for State expenses of for14 mulating source water assessment programs under section

15 1453 of such Act, $85,000,000, to remain available until

16 expended.

17 Hereafter, source water assessment programs under

18 section 1453 of such Act shall include (1) the assessment

19 of the pesticides chlorothalonil, pendimethalin, paraquat,

20 cyanazine, bensulide, chlorpyrifos, diazinon, metalaxyl,

21 and mecoprop; (2) the assessment of surface water

22 sources; (3) the assessment of residential drinking wells;

23 and (4) the assessment of contaminated soil.

Æ
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

HEADWATER RESEARCH LLC,

Plaintiff,

v. 

SAMSUNG ELECTRONICS CO., LTD., 

and SAMSUNG ELECTRONICS 

AMERICA, INC.,

Defendants.

§

§

§

§

§

§

§

§

§

§

§

§

CIVIL ACTION NO. 2:23-CV-00103-JRG-RSP

ORDER

Before the Court is the Joint Motion to Amend Docket Control Order filed by Plaintiff 

Headwater Research LLC, and Defendants Samsung Electronics Co., Ltd., and Samsung 

Electronics America, Inc. Dkt. No. 281. The Parties request a brief extension of the deadline to 

file the Joint Proposed Jury Instructions and Joint Proposed Verdict Form. After consideration, 

and noting its joint nature, the Motion is GRANTED. 

It is ORDERED that the Parties’ deadline to file the Joint Proposed Jury Instructions and 

Joint Proposed Verdict Form is extended to December 6, 2024.

Case 2:23-cv-00103-JRG-RSP Document 282 Filed 12/05/24 Page 1 of 1 PageID #:

21352
Gregory D. KILPATRICK, petitioner, v. Fabio VOLTERRA.

No. 18-5833.

Supreme Court of the United States

Nov. 5, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
[Federal Register Volume 87, Number 96 (Wednesday, May 18, 2022)]
[Notices]
[Page 30239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10651]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Allergy, Immunology, and Transplantation 
Research Committee Allergy, Immunology, and Transplantation Research 
Committee (AITC).
    Date: June 9-10, 2022.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20892-9834d, (240) 669-5060, <a href="/cdn-cgi/l/email-protection#89e3e8e4ecfaa7fae7f0edecfbc9e7e0e1a7eee6ff"><span class="__cf_email__" data-cfemail="9ef4fff3fbedb0edf0e7fafbecdef0f7f6b0f9f1e8">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 12, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-10651 Filed 5-17-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 87, Number 96 (Wednesday, May 18, 2022)]
[Notices]
[Page 30233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10627]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Integrative Health; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel; NIH-DoD-VA Pain 
Management Collaboratory Demonstration Projects (UG3/UH3).
    Date: June 17, 2022.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Center for Complementary and Integrative, 
Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Sonia Elena Nanescu, Ph.D., Scientific Review 
Officer, Office of Scientific Review, Division of Extramural 
Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, 
Bethesda, MD 20892-5475, <a href="/cdn-cgi/l/email-protection#3e4d5150575f10505f505b4d5d4b7e50575610595148"><span class="__cf_email__" data-cfemail="cdbea2a3a4ace3a3aca3a8beaeb88da3a4a5e3aaa2bb">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training in Complementary and Alternative Medicine, 
National Institutes of Health, HHS)

    Dated: May 12, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-10627 Filed 5-17-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Joseph BURRIS, petitioner, v. Eileen RAMEY, Superintendent, Jefferson City Correctional Center.

No. 18-6088.

Supreme Court of the United States

Nov. 5, 2018.

Petition for writ of certiorari to the Supreme Court of Missouri denied.
1

The Honorable James E. Gritzner, United States District Judge for the

Southern District of Iowa.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 03-1392

___________

United States of America, *

*

Appellee, *

* Appeal from the United States

v. * District Court for the

* Southern District of Iowa.

Raymond J. Ramirez, *

* [UNPUBLISHED]

Appellant. *

___________

 Submitted: September 19, 2003

 Filed: September 29, 2003

___________

Before RILEY, HANSEN, and SMITH, Circuit Judges.

___________

PER CURIAM.

Pursuant to a written plea agreement, Raymond Ramirez (Ramirez) pled guilty

to conspiring to distribute cocaine base, in violation of 21 U.S.C. §§ 846 and

841(b)(1)(B). The district court1

 sentenced Ramirez to 120 months imprisonment and

8 years supervised release. On appeal, Ramirez’s counsel has moved to withdraw and

filed a brief under Anders v. California, 386 U.S. 738 (1967), arguing the government

unreasonably refused to file a motion for a downward departure based upon

Ramirez’s substantial assistance.
-2-

In the plea agreement, however, Ramirez waived his right to appeal, with

limited exceptions not applicable here. After carefully reviewing the record, we

conclude Ramirez’s challenge to his sentence is within the scope of the waiver, he

entered into the plea agreement knowingly and voluntarily, and no miscarriage of

justice would result from enforcing the waiver. See United States v. Andis, 333 F.3d

886, 889-91 (8th Cir. 2003) (en banc). Accordingly, we dismiss this appeal and grant

counsel’s motion to withdraw.

______________________________
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT

TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies that (1) this Annual Report of Bankrate, Inc. (the
Company) on Form 10-K for the period ended December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (this Report), fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934, as amended, and (2) the information contained in this Report fairly presents, in all material respects, the financial condition of the Company as of December 31, 2008 and 2007, and its results of operations
for each of the years in the three-year period ended December 31, 2008.



|               |  |  |  |                                      
|-------------- |  |  |  | -------------------------------------
|March 13, 2009 |  |  |  | /s/    THOMAS R. EVANS               
|               |  |  |  | Thomas R. Evans                      
|               |  |  |  | President and Chief Executive Officer

A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.
Carl B. DAVIS, Chapter 13 Trustee, petitioner, v. TYSON PREPARED FOODS, INC.

No. 18-941.

Supreme Court of the United States

May 20, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.
Zaamar Bersan STEVENSON, petitioner, v. PENNSYLVANIA BOARD OF PROBATION AND PAROLE, et al.

No. 18-8933.

Supreme Court of the United States

June 24, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.